The company published a presentation elaborating on the company’s overall strategy to discover, develop and commercialize novel therapeutics from its proprietary cannabinoid product platform.
Read More
“DTC eligibility” simplifies the process of trading and transferring the Company’s common shares between brokerages in the U.S.
Read More
HEXO) becomes the first cannabis company to join Food & Consumer Products of Canada (FCPC),...
Read More
Health Canada issued Lotus Cannabis with a “standard cultivation” licence and a “sale for medical...
Read More
Get stock alerts, news & related alerts straight to your inbox!